amlodipine has been researched along with Graft Occlusion, Vascular in 2 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.
Excerpt | Relevance | Reference |
---|---|---|
"The pharmacodynamic analysis end point was clopidogrel on-treatment platelet reactivity (OPR) and the clinical analysis end point was the composite of cardiac death, non-fatal myocardial infarction, ischaemic stroke and stent thrombosis at 12 months post-PCI." | 3.78 | Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention. ( Kang, HJ; Kang, J; Kim, HS; Koo, BK; Lee, HY; Oh, BH; Park, JJ; Park, KW; Park, YB; Yang, HM, 2012) |
" However, the concentrations at which these calcium channel blockers elicit antiproliferative effects may not be attainable during therapeutic dosing in humans." | 1.29 | Effect of calcium channel blockers on the growth of human vascular smooth muscle cells derived from saphenous vein and vascular graft stenoses. ( Betteridge, L; Chan, P; Gallagher, K; Munro, E; Patel, M; Schachter, M; Sever, P; Wolfe, J, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Park, KW | 1 |
Kang, J | 1 |
Park, JJ | 1 |
Yang, HM | 1 |
Lee, HY | 1 |
Kang, HJ | 1 |
Koo, BK | 1 |
Oh, BH | 1 |
Park, YB | 1 |
Kim, HS | 1 |
Munro, E | 1 |
Patel, M | 1 |
Chan, P | 1 |
Betteridge, L | 1 |
Gallagher, K | 1 |
Schachter, M | 1 |
Wolfe, J | 1 |
Sever, P | 1 |
2 other studies available for amlodipine and Graft Occlusion, Vascular
Article | Year |
---|---|
Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention.
Topics: Aged; Amlodipine; Angioplasty, Balloon, Coronary; Clopidogrel; Cytochrome P-450 CYP3A; Drug Interact | 2012 |
Effect of calcium channel blockers on the growth of human vascular smooth muscle cells derived from saphenous vein and vascular graft stenoses.
Topics: Amlodipine; Cell Division; Cells, Cultured; Diltiazem; DNA; Graft Occlusion, Vascular; Humans; L-Lac | 1994 |